의료진 > 의료진/진료과 > 의료진/진료과 |강북삼성병원

내분비내과

문선준

진료분야 당뇨병(1형,2형, 췌장수술), 인공췌장클리닉(연속혈당측정, 인슐린펌프, 스마트펜), 임신성당뇨 [초진제외항목 : 갑상선(기능, 결절, 암 모두제외), 부신, 뇌하수체, 골다공증, 부갑상선질환]

진료예약

모바일로 확인하실 경우 표를 좌우로 움직여 내용을 확인 하실 수 있습니다.

0000 00
오전
오후

진료과 사정에 따라 진료 일정이 변경될 수 있습니다. 자세한 일정은 진료과로 문의 바랍니다.

외래진료
국내 학회
국외 학회
강의
휴가
기타

0000 00
오전
오후

진료과 사정에 따라 진료 일정이 변경될 수 있습니다. 자세한 일정은 진료과로 문의 바랍니다.

외래진료
국내 학회
국외 학회
강의
휴가
기타

학력 더보기

서울대학교 의과대학 의학과 졸업
서울대학교 의과대학 의학과 석사 졸업
서울대학교 의과대학 의학과 박사 수료

경력 더보기

서울대학교병원 내과 전공의
서울대학교병원 내분비내과 전임의
서울대학교병원 내분비내과 진료교수
강북삼성병원 임상조교수
강북삼성병원 조교수

학회활동 더보기

대한내분비학회 정회원
대한당뇨병학회 정회원
대한비만학회 정회원
미국내분비학회 정회원
미국당뇨병학회 정회원
前 대한내분비학회 빅데이터위원회 위원
前 대한내분비학회 연속혈당소위원회 위원
前 대한당뇨병학회 연속혈당측정 자동인슐린주입 연구회 위원
前 대한당뇨병학회 빅데이터기반 미래당뇨병 케어TFT 위원
前 대한당뇨병학회 연구위원회 위원
前 대한당뇨병학회 교과서개정 TFT 위원
現 DMJ Expert review board member
現 대한당뇨병학회 학술위원회 간사
現 대한당뇨병학회 연속혈당측정 자동인슐린주입 연구회 간사 (2형당뇨병 파트)
現 대한당뇨병학회 췌도부전TFT 위원

수상경력 더보기

2017 대한당뇨병학회 우수포스터 구연상
2018 Endocrine Week 최우수연제상
2019 Korea Clinical Datathon 2019 대상
2019 대한당뇨병학회 추계 연구비 수상
2020 대한내분비학회 EnM 연구상
2021 DMJ 우수논문상
2022 KBSMC 최고 IF 발전상

논문 더보기

Moon SJ, Ahn CH, Cho YM, Effect of prescribing metformin according to eGFR instead of serum creatinine level: A study based on Korean National Health and Nutrition Examination Survey (KNHANES) 2009-2014. PLoS One. 2017 Apr 11;12(4) e0175334. doi: 10.1371/journal.pone.0175334.
Lee HW, Moon SJ, Han HS, Shin EJ, Baek JH, Han HJ, Cho YM, Kim KS. The Effect and Safety of Dapagliflozin in Patients with Type 2 Diabetes: A Single-Institution Pharmacovigilance Review. J Korean Diabetes. 2017 Dec;18(4):275-283.
Moon SJ. Metformin-eligible patient population according to eGFR or serum creatinine level. Graduate Program in Translational Research College of Medicine. The Graduate School Seoul National University. 2018 Feb.
Min SH, Yoon JH, Moon SJ, Hahn S, Cho YM. Combination of sodium-glucose cotransporter 2 inhibitor and dipeptidyl peptidase-4 inhibitor in type 2 diabetes: a systematic review with meta-analysis. Sci Rep. 2018 Mar 13;8(1):4466. doi: 10.1038/s41598-018-22658-2.
Moon SJ, Cho YM. Insulin Treatment in Hospitalized Patients. J Korean Diabetes. 2018 Dec;19(4):214-223. https://doi.org/10.4093/jkd.2018.19.4.214
Lee C, Kim JH, Moon SJ, Shim J, Kim HI, Choi MH. Selective LC-MRM/SIM-MS based profiling of adrenal steroids reveals metabolic signatures of 17α-hydroxylase deficiency. J Steroid Biochem Mol Biol. 2020 Jan 31;198:105615.
Moon SJ, Kim JH, Kong SH, Shin CS. Protein Expression of Cyclin B1, Transferrin Receptor and Fibronectin Correlates with the Prognosis of Adrenal Cortical Carcinoma. Endocrinol Metab (Seoul). 2020 Mar;35(1):132-141.
Rhee EJ, Moon SJ, Kim JH, Lee WY. Encountering COVID-19 as Endocrinologists. Endocrinol Metab (Seoul). 2020 Apr 23;35(2):197-205
Moon SJ, Cho YM. Economic benefit of prescribing an adjusted renal dose of dipeptidyl peptidase IV inhibitors in type 2 diabetes patients with chronic kidney disease. J Diabetes. 2020 Sep;12(9) :645-648.
Lee SW, Ha EK, Yeniova A？, Moon SY, Kim SY, Koh HY, Yang JM, Jeong SJ, Moon SJ, Cho JY, Yoo IK, Yon DK. Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching. Gut. 2020 Jul 30;gutjnl-2020-322248.
Moon SJ#, Rhee EJ#, Jung JH, Han KD, Kim SR, Lee YW, Yoon KH. Independent Impact of Diabetes on the Severity of Coronavirus Disease 2019 in 5,307 Patients in South Korea: A Nationwide-Cohort Study. Diabetes Metab J. 2020 Oct;44(5):737-746. (#Co-first author)
Hong SW, Lee J, Kim MJ, Moon SJ, Kwon H, Park SE, Rhee EJ, Lee WY. Clusterin Protects Lipotoxicity-Induced Apoptosis via Upregulation of Autophagy in Insulin-Secreting Cells. Endocrinol Metab (Seoul). 2020 Dec;35(4):943-953.
Moon SJ, Rhee EJ, Lee YW, Yoon KH. Response letter: Independent Impact of Diabetes on the Severity of Coronavirus Disease 2019 in 5,307 Patients in South Korea: A Nationwide Cohort Study. Diabetes Metab J. 2020 Dec;44(6):942-943.
Bae JH, Ahn CH, Yang YS, Moon SJ, Kwak SH, Jung HS, Park KS, Cho YM. Efficacy and Safety of Self-Titration Algorithms of Insulin Glargine 300 units/mL in Individuals with Uncontrolled Type 2 Diabetes Mellitus (The Korean TITRATION Study): A Randomized Controlled Trial. Diabetes Metab J. 2021 Jun 16. doi: 10.4093/dmj.2020.0274.
Jang HN#, Moon SJ#, Jung KC, Kim SW, Kim YY, Han DH, Kim JH. Mass Spectrometry-Based Proteomic Discovery of Prognostic Biomarkers in Adrenal Cortical Carcinoma. Cancers (Basel). 2021 Aug 2;13(15):3890. (#Co-first author)
Moon SJ#, Jang HN#, Kim JH, Moon MK. Lipid Profiles in Primary Aldosteronism Compared with Essential Hypertension: Propensity-Score Matching Study. Endocrinol Metab (Seoul). 2021 Aug;36(4):885-894. (#Co-first author)
Moon SJ#, Jang HN#, Kim JH, Moon MK. Lipid Profiles in Primary Aldosteronism Compared with Essential Hypertension: Propensity-Score Matching Study. Endocrinol Metab (Seoul). 2021 Aug;36(4):885-894. (#Co-first author)
Koo DJ, Lee MY, Jung I, Moon SJ, Kwon H, Park SE, Rhee EJ, Lee WY. Baseline homeostasis model assessment of insulin resistance associated with fibrosis progression in patients with nonalcoholic fatty liver disease without diabetes: A cohort study. PLoS One. 2021 Aug 25;16(8):e0255535.
Moon SJ#, Choe HJ#, Kwak SH, Jung HS, Park KS, Cho YM. Comparison of Prevailing Insulin Regimens at Different Time Periods in Hospitalized Patients: A Real-World Experience from a Tertiary Hospital. Diabetes Metab J. 2021 Oct 20. doi: 10.4093/dmj.2021.0065. Online ahead of print. (#Co-first author)
Koo DJ, Lee MY, Jung I, Moon SJ, Kwon H, Park SE, Rhee EJ, Lee WY. Changes in Insulin Resistance Index and the Risk of Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease without Diabetes: Kangbuk Samsung Health Study. Endocrinol Metab (Seoul). 2021 Oct;36(5):1016-1028. doi: 10.3803/EnM.2021.1110. Epub 2021 Oct 21.
Moon SJ#, Jung I#, Park CY. Current Advances of Artificial Pancreas Systems: A Comprehensive Review of the Clinical Evidence. Diabetes Metab J. 2021;45(6):813-839. doi:10.4093/dmj.2021.0177. (#Co-first author)
Lee J, Hong SW, Kim MJ, Moon SJ, Kwon H, Park SE, Rhee EJ, Lee WY. Dulaglutide Ameliorates Palmitic Acid-Induced Hepatic Steatosis by Activating FAM3A Signaling Pathway. Endocrinol Metab (Seoul). 2022 Feb;37(1):74-83. doi: 10.3803/EnM.2021.1293. Epub 2022 Feb 9.
Koo DJ, Lee MY, Jung I, Moon SJ, Kwon H, Rhee EJ, Park CY, Lee WY, Oh KW, Park SE. Increased Risk of NAFLD in Adults with Glomerular Hyperfiltration: An 8-Year Cohort Study Based on 147,162 Koreans. J Pers Med. 2022 Jul 14;12(7):1142. doi: 10.3390/jpm12071142.
Moon SJ#, Kim KS#, Lee WJ, Lee MY, Vigersky R, Park CY. Efficacy of intermittent short-term use of a real-time continuous glucose monitoring system in non-insulin-treated patients with type 2 diabetes: A randomized controlled trial. Diabetes Obes Metab. 2023 Jan;25(1):110-120. doi: 10.1111/dom.14852. Epub 2022 Sep 23. (#Co-first author)
Kwon H, Han KD, Kim BS, Moon SJ, Park SE, Rhee EJ, Lee WY. Acromegaly and the long-term fracture risk of the vertebra and hip: a national cohort study. Osteoporos Int. 2023 May 24. doi: 10.1007/s00198-023-06800-z. Online ahead of print.
Jung I, Han KD, Moon SJ, Kwon H, Park SE, Rhee EJ, Lee WY. Association of physical activity with total and cause-specific mortality in patients with diabetes: A nationwide population-based cohort study. Diabetes Res Clin Pract. 2023 Aug;202:110819. doi: 10.1016/j.diabres.2023.110819. Epub 2023 Jul 7.
Moon SJ, Lee WY. Importance of continuous glucose monitoring in the treatment of diabetes mellitus. Korean Med Assoc. 2023 Jul;66(7):432-438.doi: 10.5124/jkma.2023.66.7.432
Ko J, Moon SJ. Risk of Diabetic Retinopathy between Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists (Diabetes Metab J 2023;47:394-404). Diabetes Metab J (IF: 5.38; Q1). 2023 Jul;47(4):571-572. doi: 10.4093/dmj.2023.0164. Epub 2023 Jul 27.
Koo DJ, Lee MY, Moon SJ, Kwon H, Lee SM, Park SE, Park CY, Lee WY, Oh KW, Cho SR, Jeong YH, Rhee EJ. Coronary Artery Calcium Score as a Sensitive Indicator of Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus: A Long-Term Cohort Study. Endocrinol Metab (Seoul) (IF: 4.01; Q3). 2023 Oct;38(5):568-577. doi: 10.3803/EnM.2023.1770. Epub
Kwon H, Han KD, Moon SJ, Park SE, Rhee EJ, Lee WY. Nonalcoholic Fatty Liver Disease and the Risk of Thyroid Cancer Among Young Adults in South Korea. J Clin Endocrinol Metab. 2023 Oct 31:dgad575. doi: 10.1210/clinem/dgad575. Online ahead of print.
Moon SJ#, Ahn CH#, Lee YB, Cho YM. Impact of Hyperglycemia on Complication and Mortality after Transarterial Chemoembolization for Hepatocellular Carcinoma. Diabetes Metab J. 2024 Mar;48(2):302-311. doi: 10.4093/dmj.2022.0255. Epub 2024 Jan 3.
Lee J, Hong SW, Kim MJ, Lim YM, Moon SJ, Kwon H, Park SE, Rhee EJ, Lee WY. Inhibition of Sodium-Glucose Cotransporter-2 during Serum Deprivation Increases Hepatic Gluconeogenesis via the AMPK/AKT/FOXO Signaling Pathway. Endocrinol Metab (Seoul). 2024 Feb;39(1):98-108. doi: 10.3803/EnM.2023.1786. Epub 2024 Jan 3.
Lee J, Hong SW, Kim MJ, Moon SJ, Kwon H, Park SE, Rhee EJ, Lee WY. Glucagon-Like Peptide Receptor Agonist Inhibits Angiotensin II-Induced Proliferation and Migration in Vascular Smooth Muscle Cells and Ameliorates Phosphate-Induced Vascular Smooth Muscle Cells Calcification. Diabetes Metab J. 2024 Jan;48(1):83-96. doi: 10.4093/dmj.2022.0363. Epub 2024 Jan 3.
Hong SW, Lee J, Moon SJ, Kwon H, Park SE, Rhee EJ, Lee WY. Docosahexanoic Acid Attenuates Palmitate-Induced Apoptosis by Autophagy Upregulation via GPR120/mTOR Axis in Insulin-Secreting Cells. Endocrinol Metab (Seoul). 2024 Apr;39(2):353-363. doi: 10.3803/EnM.2023.1809. Epub 2024 Jan 23.
Jang HN#, Moon SJ#, Jung JH, Han KD, Rhee EJ, Lee WY. Impact of Antidiabetic Drugs on Clinical Outcomes of COVID-19: A Nationwide Population-Based Study. Endocrinol Metab (Seoul). 2024 Jan 29. doi: 10.3803/EnM.2024.1857. Online ahead of print.
Kim JY, Jin SM, Kang ES, Kwak SH, Yang Y, Yoo JH, Bae JH, Moon JS, Jung CH, Bae JC, Suh S, Moon SJ, Song SO, Chon S, Kim JH. Comparison between a tubeless, on-body automated insulin delivery system and a tubeless, on-body sensor-augmented pump in type 1 diabetes: a multicentre randomised controlled trial. Diabetologia. 2024 Apr 18. doi: 10.1007/s00125-024-06155-y. Online ahead of print.
Klonoff DC, Gabbay M, Moon SJ, Wilmot EG. Importance of FDA-Integrated Continuous Glucose Monitors to Ensure Accuracy of Continuous Glucose Monitoring. J Diabetes Sci Technol. 2024 May 3:19322968241250357. doi: 10.1177/19322968241250357. Online ahead of print.

건강정보 더보기

서울특별시 종로구 새문안로 29 (03181) 강북삼성병원

대표전화 1599-8114

팩스번호 02-2001-2117

사업자번호 110-82-02349